Table 2.
Sub-group analysis.
| Killip grade I | Killip grade II | Killip grade III–IV | ||||
|---|---|---|---|---|---|---|
| NFHG n = 216 | FHG n = 140 | NFHG n = 82 | FHG n = 70 | NFHG n = 15 | FHG n = 40 | |
| Gender, male, % | 186 (86.1) | 101 (72.1)* | 65 (79.3) | 53 (75.7) | 14 (93.3) | 29 (72.5) |
| Age, year, ±s | 61.8 ± 12.8 | 63.2 ± 13.2 | 64.2 ± 12.2 | 65.0 ± 12 | 65.7 ± 4.1 | 64.0 ± 2.4 |
| Left ejection fraction ±s | 0.54 ± 0.11 | 0.51 ± 0.13 | 0.50 ± 0.11 | 0.46 ± 0.12 | 0.46 ± 0.11 | 0.45 ± 0.13 |
| Serum potassium ±s | 3.82 ± 0.40 | 3.80 ± 0.42 | 3.82 ± 0.36 | 3.82 ± 0.46 | 3.79 ± 0.46 | 3.78 ± 0.42 |
| Left atrial diameter ±s | 34.8 ± 5.8 | 34.1 ± 8.3 | 37.1 ± 8.1 | 36.2 ± 8.0 | 34.8 ± 5.8 | 34.1 ± 8.3 |
| Diabetes, n % | 16 (7.4) | 28 (20.0) | 8 (9.8) | 8 (11.4) | 2 (13.3) | 9 (22.5) |
| Hypertension, n% | 94 (43.5) | 64 (45.7) | 38 (46.3) | 33 (47.1) | 5 (33.3) | 17 (42.5) |
| Rate of new onset fibrillation, n, % | 14 (6.5) | 23 (16.4)* | 10 (12.2) | 15 (21.4)§ | 5 (33.3) | 16 (40) |
Baseline characteristic and new onset AF comparation between NFHG group and FHG group under different killip level.
*
p < 0.01;
§
p < 0.001.